Aplasia de Medula Óssea: Diagnóstico e Tratamento

Caderno de AnotaçõesAplasia de Medula óssea: Diagnóstico e Tratamento

Prof. Dr. Harald Brito

Material exclusivo Qualittas

!"#$%&'(

)#*"+,"(-"(.&-/*"(0++&"1(-$(

-,"230+45$("$('6"'".&3'$(!6$78(968(:"6"*-(;8(<8(=6,'$(

>&-/*"(0++&"(

WEISS, D.J.; WARDROP, K.J. (Ed.). Schalm's veterinary hematology. John Wiley

& Sons, 2011.

?3-,5"@A&+(#"6"(.,&*$26"."(

•  )3&.,"+("#*B+,5"1(

–  C&45/*05,'$+(5$66,2,-$+(

((((D(EF(

F(5$66(G(F(5$3'(H(:'(I(:'x+#(

•  J&/5$#&3,"(

•  K6$.L$5,'$#&3,"(

M$.#"6"@N$(&3'6&("3&.,"(7&66$#6,%"(&("3&.,"(#$6(

-$&3@"(,3O"."'06,"(P"-"#'"-$(-&(:"6%&QR(STESU(

!"#$%&'#()*&%"'(+,-./() 01&%.")2&##(3#.4") 01&%.")3(#)5(&16")

.17"%"',#.")

:&."'056,'$( !(*&%&("("5&3'/"-"( !(*&%&("(.$-&6"-"(

<M>( !(*&%&("("5&3'/"-"( V$6."*($/(!(*&%&(

;&66$(+W6,5$( !(*&%&("("5&3'/"-"( !(*&%&("(.$-&6"-"(

MJ;K( V$6."*($/("( V$6."*($/(!(

;&66,43"( !( V$6."*($/("(

9&#$+,@N$(-&(

X&.$++,-&6,3"(

!($/("/+&3'&( V$6."*($/("(

)3&.,"("66&2&3&6"4%"(5$.(*&/5$#&3,"(&Y$/(

'6$.L$5,'$#&3,"(

03+"8.")5")%&59+"),88&")

•  :,#$#*"+,"1((

–  >&-/*"(0++&"(G(Z[SZF(-$(

&+#"@$(X&."'$#$,W45$(

•  )#*"+,"1(

–  >&-/*"(0++&"(D(ZF(-$(&+#"@$(

X&."'$#$,W45$((

:.&+(;8./")

•  V&$#*"+,"+(

–  J,37$."(./*45\3'6,5$(

•  >,&*$]L6$+&(

•  >,&*$3&56$+&(

•  ^+'&$#&'6$+&(

•  C"-,"@N$(

>,&*$]L6$+&(

<"98"8)

•  ?3O"."@N$(

•  V&56$+&(

•  V&$#*"+,"(

–  !6,.B6,"($/(+&5/3-B6,"(

•  _/L+'`35,"+('0H,5"+(

=&%(-#"%")

>,&*$]L6$+&(Y(>,&*$3&56$+&(

•  !/3@N$(+&5"(

–  )#&3"+(+32(#&6,7W6,5$(

–  =,0#+,"(-&(5&3'6$(-"(

.&-/*"(

aX6*,5X,$+&(

•  !"35,'$#&3,"(

•  K6"'".&3'$(

– 9$H,5,5*,3"(

Kbc"(&'("*8()34L,$45+(."Q(,.#",6(X&."'$#$,&45(6&5$%&6Q(

"d&6(5Q'$'$H,5(.Q&*$"L*"4$38(>+((5R(

%8(EEeR(38(fR(#8(EgTh[EgTiR(STTi8(

(

^3-&(5$*X&6(.&-/*"(0++&"j(

M$*X&3-$(.&-/*"(0++&"k(

M$*X&3-$(.&-/*"(0++&"k(

M$*X&3-$(.&-/*"(0++&"(

>,&*$26"."(

>,&*$26"."(

K6"'".&3'$(

•  ;,*26"+4.(

–  M_;([(PX/."3$U(

–  a+4./*"(l(3&/'60]*$+(

–  Z(m2Yn2Y-,"(

•  M$L".".,-"(

–  M$&3o,."(-"(%,'(=ES(

– "(+p3'&+&(#6$'W,5"(

–  Z[ET(.2Y-,"(

K6"'".&3'$(

•  K,.$.$-/*,3"(

–  )@N$(,./3$(&(

.,&*$.$-/*"-$6"(

–  a+4./*"(-,7&6&35,"@N$(

-&(*,3705,'$+(K(

–  q(.2Yn2Y-,"(

•  V"3-6$*$3"(

–  )3"L$*,o"3'&(

"3-6$2\3,5$(

– "(#6$-/@N$(-&(a!^(

–  Z[EZ(.2(

K6"'".&3'$(•  >_M(

–  C&5$3X&5&.(+p4$+(-&(,3b/6,"('&5,-/"*(

–  )@N$(#"6B56,3"(

–  ?./3$.$-/*"@N$(-$(.,56$".L,&3'&(

–  K"."3X$(-"+(5W*/*"+("/.&3'"(3$(5/*4%$(

;?_M:aCR(r8(>8(&'("*8(!/*.$3"6Q(#"++"2&(,+("(."b$6($L+'"5*&(7$6(,3'6"%&3$/+(+'&.(5&**(-&*,%&6Q1('X&(#/*.$3"6Q(]6+'[#"++(&s&5'8(?'&%)<&++8)"15)@&4&+(3%&1'R(%8(EhR(38(ZR(#8(ghe[giSR(STTi8(

K6"'".&3'$(

•  K>^(–  !6$2&3,'$6"+(X&."'$#$,W45"+(

•  M9eql(

–  >&-/*"("L6,2"(!"##(-&(5W*/*"+['6$35$(

–  >,26"@N$(.&-,"-"(#&*"+(t/,.,$5,3"+(_9;[E(&(MuMJES(

K6"'".&3'$(

•  K>^(

–  >",$6&+(*,.,'"@A&+1(

•  K&+'&(-&(5$.#"4L,*,-"-&(

v)wVaCR(x8(J8(>$*&5/*"6($62"3,o"4$3($7(

'X&(5"3,3&(."b$6(X,+'$5$.#"4L,*,'Q(

5$.#*&H8(A(9#1"+)(2)=&#&5.'BR(%8(iqR(38(ER(#8(

Se[SgR(STTe8(

•  )%"*,"@N$(#6W%,"(-"(

.&-/*"(

M:?M)R(_C9R(SZn2(

#  Aplasia por quimioterapia

#  3 Transfusões

# Biópsia de MO = aplasia

#  VG 16%

#  Hemácias 2,1mi/µL

#  Leucócitos 2.400/µL

#  3 dias

# VG 17%

# Hemácias 2,3mi/µL

#  Leucócitos 3.260/µL

M$3'6$*&+(

#  15 dias

# VG 28%

# Hemácias 3,62x106/µL

# Leucócitos 5.000/µL

#  9 dias

# VG 21%

# Hemácias 2,59x106/µL

# Leucócitos 3.350/µL

M$3'6$*&+(

# 180 dias # VG 49%

# Hemácias 7,22x106/µL

# Leucócitos 5.100/µL

# Plaquetas 194.000/µL

# 100 dias

# VG 39%

# Hemácias 6,07x106/µL

# Leucócitos 6.300/µL

X"6"*-L6,'$y.&85$.(

(

X"6"*-%&'yQ"X$$85$.8L6(